Advanced Drug Sciences (ADS) is an international, peer-reviewed, Gold Open Access journal dedicated to publishing high-quality research that advances the science of drug discovery, development, and therapeutic application. The journal provides a multidisciplinary platform for disseminating innovative experimental, computational, translational, and clinical research across the pharmaceutical and biomedical sciences.
ADS welcomes original research articles, systematic reviews and meta-analyses, review articles, short communications, method articles, perspectives, and scholarly commentaries covering medicinal chemistry, drug design, pharmaceutical technology, drug delivery systems, pharmacology, toxicology, clinical pharmacy, regulatory science, pharmacovigilance, pharmacoeconomics, and emerging interdisciplinary fields including pharmaceutical biotechnology, artificial intelligence, systems biology, biomaterials, and precision medicine.
The journal is committed to scientific rigor, research integrity, transparency, and reproducibility through a rigorous peer-review process. By fostering interdisciplinary collaboration and promoting open scientific communication, ADS aims to accelerate pharmaceutical innovation and facilitate the translation of scientific discoveries into improved therapeutic outcomes and global healthcare.
Current Issue
Vol. 1 No. 1 (2026): Inaugural Issue
Welcome to the inaugural issue of Advanced Drug Sciences (ADS). This issue is published under the journal's continuous publication model, enabling accepted articles to be published online individually immediately after completion of peer review, editorial processing, and production. Additional articles will be added to this issue as they become publication-ready until the issue is formally closed according to the journal's publication schedule. The articles published in this issue reflect the journal's commitment to scientific excellence, methodological rigor, research integrity, interdisciplinary collaboration, and responsible pharmaceutical innovation across the pharmaceutical sciences. We sincerely thank our authors, reviewers, Editorial Board members, and readers for their support in launching Advanced Drug Sciences and look forward to advancing pharmaceutical research together through high-quality scholarly communication.
Published: 2026-06-30
Research Article
Review Article
Advanced Drug Sciences (ADS)
An international, peer-reviewed open access journal publishing high-quality research in drug discovery, pharmaceutical sciences, and translational applications.
About the Journal
Advanced Drug Sciences (ADS) is an international peer-reviewed journal dedicated to publishing high-quality research across drug discovery, pharmaceutical sciences, and translational medicine. The journal emphasizes methodological rigor, scientific innovation, and real-world application.
Editorial Leadership
The journal is led by an international editorial team committed to maintaining high standards of peer review, transparency, and scientific integrity.
View Editorial Board →Abstracting & Indexing
ADS is committed to global visibility and discoverability. Articles are assigned DOIs via Crossref, and the journal will apply for inclusion in major indexing databases following publication of initial issues.
Learn more →Policies & Ethics
Why Publish in ADS?
- Rigorous peer review
- Rapid editorial decision
- Open access visibility
- Strong editorial governance
Title: Advanced Drug Sciences
Initials: ADS
Abbreviation: Adv. Drug Sci.
Publication Frequency: Quarterly
Publishing Model: Continuous publication with quarterly issues
Open Access Model: Gold Open Access
ISSN: XXXX-XXXX (In progress)
Publisher: Universitas Muhammadiyah Surakarta, Indonesia